BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
BioTelemetry (BEAT) Tops Q2 EPS by 19c
July 30, 2020 4:16 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.35, $0.19 better than the analyst estimate of $0.16. Revenue for the quarter came in at $99.1 million versus the consensus estimate of $89.52 million.
President and CEO Commentary
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:
Due to the unwavering commitment of the entire BioTelemetry team, we continued to successfully navigate the current external... More



